Praziquantel's Effects on Liver Fibrosis in Mice with Schistosomiasis
Author Information
Author(s): Liang Yue-Jin, Luo Jie, Yuan Quan, Zheng Dan, Liu Ya-Ping, Shi Lei, Zhou Ying, Chen Ai-Ling, Ren Yong-Ya, Sun Ke-Yi, Sun Yan, Wang Yong, Zhang Zhao-Song
Primary Institution: Nanjing Medical University, Nanjing, Jiangsu, China
Hypothesis
Does praziquantel have a direct therapeutic action on liver fibrosis caused by Schistosoma japonicum infection?
Conclusion
Praziquantel significantly improves liver fibrosis in mice infected with Schistosoma japonicum.
Supporting Evidence
- Praziquantel treatment reduced liver fibrosis as measured by Sirius Red staining.
- Serum ALT levels decreased significantly after praziquantel treatment.
- Collagen deposition in the liver was significantly reduced in treated mice.
Takeaway
Praziquantel, a drug used to treat parasitic infections, can also help heal liver damage caused by a specific parasite in mice.
Methodology
Mice were infected with Schistosoma japonicum and treated with praziquantel to assess its antifibrotic effects through various measurements including liver collagen deposition and serum ALT levels.
Potential Biases
Potential bias in the selection of treatment dosages and control groups.
Limitations
The study was conducted on mice, which may not fully replicate human responses.
Participant Demographics
Female BABL/c mice, 6–8 weeks old.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website